Scroll ahead to see all the highlights you may have missed from the 2025 awards show. As the team members behind No Other Land accepted their Best Documentary award, they delivered an incredibly ...

Recent Highlights Muscular Dystrophy Program / Sevasemten Sevasemten and Becker Sevasemten is an orally administered first-in-class fast skeletal myosin inhibitor designed to protect muscle ...

Equipment plays a key role in the eventual outcome on a match. Tennis is no different and it has become more evident with what happened in the recent past. Two players who struggled massively have ...

Leah Pruett, wife of Tony Stewart, recently updated her Instagram story as she enjoyed her vacation with her son Dominic James Stewart. The drag racer has been on a break from racing since 2024 ...

today reported fourth quarter and full year 2024 financial results and highlighted recent pipeline and business progress. "Heading into 2025, Ventyx has established itself as the leader in the field ...

WPL Live Score, Gujarat Giants vs Mumbai Indians Highlights: All-rounder Nat Sciver-Brunt starred in both departments as Mumbai Indians produced a clinical performance to return to winning ways ...

Feb. 27, 2025 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies, today ...

Recent and Upcoming Milestones Aleniglipron (GSBR-1290) – Oral Small Molecule Selective GLP-1R Agonist for Obesity Enrollment in both the ACCESS and ACCESS II studies, totaling over 300 patients ...

Avidity reported its 2025 outlook, including upcoming clinical and regulatory highlights, and recent organization appointments to execute on the full range of strategic initiatives and growth ...

Important factors that could cause actual results to differ materially from those in the forward-looking statements are set forth in our most recent Annual Report on Form 10-K and any subsequent ...

today reported financial results for the fourth quarter and full year 2024 and recent business highlights. “Our most recent clinical data for DYNE-101 from the ACHIEVE trial in DM1 patients ...